News

The NIH grant of $299,585 is for the first year of a two-year project period beginning this July. The grant will be used to support the preclinical testing

The tablet combines Gilead’s emtricitabine 200mg and tenofovir alafenamide (TAF) 25mg with Janssen Sciences Ireland’s rilpivirine 25mg (R/F/TAF). The company said that the data submitted in the NDA

DE-122 is the ophthalmic formulation of Santen’s partner Tracon Pharmaceuticals’ anti-endoglin antibody, TRC105. In March last year, Santen licensed the global rights for the development of TRC105 in

AV-101 is a clinical-stage prodrug candidate that readily gains access to the central nervous system (CNS) after systemic administration and is rapidly converted in vivo to its active

The decision to cease distribution follows a negative outcome of price negotiations with the GKV-Spitzenverband, the German national association of statutory health insurance funds. Tresiba provides an ultra-long

Pickwick will focus on assisting Nutra Pharma in its strategies for maximizing shareholder value through its full scope of investment banking services. "Nutra Pharma is in the process

Stuart W. Titus, PhD, President and CEO of Medical Marijuana Inc. mentions: "We are extremely excited to announce our strategic ownership interest in AXIM Biotech and explain to

With the close of this acquisition, management believes that the Company will be able to offer comprehensive immuno-oncology cell therapy portfolios, as well as a broad set of

The Phase 1 study will evaluate the safety and immune response profile of the DPX-RSV vaccine candidate in healthy adults. The study, conducted at the Canadian Center for